Interleukin-2 before surgery prolongs survival in colorectal cancer patients

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1829 / 1830
页数：2
相关论文
共 50 条
  • [11] A multistep therapy with subcutaneous low dose recombinant interleukin-2, 5-fluorouracil and leucovorin prolongs the response of metastatic colorectal cancer patients: a pilot study
    Nicolini, A
    Carpi, A
    Ferrari, P
    Sagripanti, A
    Anselmi, L
    BIOMEDICINE & PHARMACOTHERAPY, 1998, 52 (7-8) : 311 - 316
  • [12] INTERLEUKIN-2 AND CANCER
    BUBENIK, J
    SIMOVA, J
    BUBENIKOVA, D
    FOLIA BIOLOGICA, 1992, 38 (3-4) : 155 - 169
  • [13] INTERLEUKIN-2 AND CANCER
    FERNANDEZCRUZ, E
    MEDICINA CLINICA, 1986, 87 (01): : 21 - 23
  • [14] A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients with advanced colorectal cancer
    Fiedler, W
    Krüger, W
    Laack, E
    Mende, T
    Vohwinkel, G
    Hossfeld, DK
    ONCOLOGY REPORTS, 2001, 8 (02) : 225 - 231
  • [15] RECOMBINANT INTERLEUKIN-2 TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - EFFECT ON NATURAL CYTOTOXICITY
    PARK, KGM
    HEYS, SD
    MURRAY, JB
    HAYES, PD
    ASHBY, JA
    FRANKS, CR
    EREMIN, O
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 35 (01) : 53 - 58
  • [16] Immunobiological effects of interleukin-2, interleukin-12 or interleukin-2 plus interleukin-12 in metastatic cancer patients
    Lissoni, P
    Barni, S
    Mandala, M
    Rovelli, F
    Cangemi, G
    Fumagalli, L
    Pirato, D
    Vigore, L
    Roselli, MG
    Tancini, G
    Vigano, MG
    Giani, L
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1998, 14 (01): : 41 - 44
  • [17] Epigenetic alteration prolongs female survival in colorectal cancer
    Bredbeck, Brooke C.
    Burlew, Clay Cothren
    Weber, Sharon M.
    Barnett, Carlton C., Jr.
    SURGERY, 2015, 158 (05) : 1165 - 1167
  • [18] SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR IN COLORECTAL-CANCER
    MURAKAMI, S
    SATOMI, A
    ISHIDA, K
    MURAI, H
    OKAMURA, Y
    ACTA ONCOLOGICA, 1994, 33 (01) : 19 - 21
  • [19] INVIVO ADMINISTRATION OF PURIFIED HUMAN INTERLEUKIN-2 TO PATIENTS WITH CANCER - DEVELOPMENT OF INTERLEUKIN-2 RECEPTOR POSITIVE CELLS AND CIRCULATING SOLUBLE INTERLEUKIN-2 RECEPTORS FOLLOWING INTERLEUKIN-2 ADMINISTRATION
    LOTZE, MT
    CUSTER, MC
    SHARROW, SO
    RUBIN, LA
    NELSON, DL
    ROSENBERG, SA
    CANCER RESEARCH, 1987, 47 (08) : 2188 - 2195
  • [20] Zolbetuximab prolongs survival in cancer patients
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (12): : 1578 - +
12345